Skip to main content

Idexx Laboratories Inc. Value Stock - Dividend - Research Selection

Idexx

ISIN: US45168D1046 , WKN: 888210

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. It also offers diagnostic and health-monitoring products for livestock, poultry, and dairy markets; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Idexx (IDXX) Down 3.2% Since Last Earnings Report: Can It Rebound?

2026-06-04
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IDEXX Parasite Test Expansion Links Zoonotic Risk And Valuation Debate

2026-06-03
IDEXX Laboratories (NasdaqGS:IDXX) has expanded its Fecal Dx antigen testing to detect taeniid tapeworm in companion animals. The broadened panel includes medically significant Echinococcus species, a key zoonotic parasite of concern for veterinarians and public health officials. The update targets regions where taeniid tapeworm and Echinococcus are a growing focus for disease surveillance and prevention. IDEXX Laboratories, a veterinary diagnostics and software company, continues to build...

Zoetis: Potential Deep Value Play With 60%+ Upside Potential Dividend Investors Should Watch

2026-06-02
Zoetis stock fell 50% amid inflation and demand worries. Click here to read more on the stock's dividend safety, valuation, upside potential, and risks.

Baron Asset Fund Q1 2026 Contributors, Detractors And Recent Activity

2026-06-01
SpaceX is generating significant value with the rapid expansion of its Starlink broadband service. Read more here.

Tracking Terry Smith's Fundsmith 13F Portfolio - Q1 2026 Update

2026-05-31
Fundsmith's 13F portfolio value declined to $12.83B with holdings reduced from 37 to 34; the top five holdings comprise ~38% of assets. Read the full analysis now.

IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference

2026-05-30
IDEXX Laboratories (NASDAQ:IDXX) President and CEO Michael Erickson used a Stifel investor conference appearance to emphasize the company’s innovation pipeline, expanding commercial reach and growing use of software and artificial intelligence across veterinary diagnostics. Erickson, who recently b

IDEXX Laboratories (IDXX) Embeds an Early Kidney Disease Detector Into Its Most Popular Test Profile

2026-05-27
IDEXX Laboratories, Inc. (NASDAQ:IDXX) is one of the best medical technology stocks to buy right now. On May 19, IDEXX Laboratories, Inc. (NASDAQ:IDXX) announced that its SDMA kidney biomarker will be built directly into Catalyst CLIPs. Catalyst CLIPs is the most widely used point-of-care chemistry profiles on the company’s Catalyst platform. IDEXX said this integration […]

IDEXX Laboratories, Inc. (IDXX) Presents at Stifel Jaws & Paws Conference 2026 Transcript

2026-05-27
IDEXX Laboratories, Inc. (IDXX) Stifel Jaws & Paws Conference 2026 May 27, 2026 10:55 AM EDTCompany ParticipantsMichael Erickson - CEO, President &...

Is Wall Street Bullish or Bearish on IDEXX Laboratories Stock?

2026-05-26
Although IDEXX Laboratories has lagged the broader market over the past year, Wall Street analysts remain fairly bullish about the company’s long-term growth prospects.

IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection

2026-05-26
WESTBROOK, Maine, May 26, 2026--IDEXX expands Fecal Dx™ antigen testing with taeniid tapeworm detection for broader intestinal parasite screening in wellness and sick-pet care.